Skip to main content
. 2018 Sep 21;173(1):123–133. doi: 10.1007/s10549-018-4964-y

Fig. 2.

Fig. 2

Percent clinical response to neoadjuvant letrozole by Recurrence Score Group (N = 295); CR complete response, PD progressive disease, PR partial response, RS Recurrence Score, SD stable disease